ALUR vs. KRMD, BLUA, BWAY, TELA, STIM, NVNO, SEPA, PDEX, SRTS, and MGRM
Should you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include KORU Medical Systems (KRMD), BlueRiver Acquisition (BLUA), BrainsWay (BWAY), TELA Bio (TELA), Neuronetics (STIM), enVVeno Medical (NVNO), SEP Acquisition (SEPA), Pro-Dex (PDEX), Sensus Healthcare (SRTS), and Monogram Orthopaedics (MGRM). These companies are all part of the "surgical & medical instruments" industry.
Allurion Technologies (NYSE:ALUR) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, community ranking, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.
Allurion Technologies has a net margin of 0.00% compared to KORU Medical Systems' net margin of -45.24%. Allurion Technologies' return on equity of 0.00% beat KORU Medical Systems' return on equity.
KORU Medical Systems received 33 more outperform votes than Allurion Technologies when rated by MarketBeat users. However, 100.00% of users gave Allurion Technologies an outperform vote while only 60.00% of users gave KORU Medical Systems an outperform vote.
Allurion Technologies currently has a consensus price target of $5.00, suggesting a potential upside of 164.55%. KORU Medical Systems has a consensus price target of $3.50, suggesting a potential upside of 55.56%. Given Allurion Technologies' higher probable upside, research analysts clearly believe Allurion Technologies is more favorable than KORU Medical Systems.
KORU Medical Systems has lower revenue, but higher earnings than Allurion Technologies.
In the previous week, Allurion Technologies had 8 more articles in the media than KORU Medical Systems. MarketBeat recorded 11 mentions for Allurion Technologies and 3 mentions for KORU Medical Systems. Allurion Technologies' average media sentiment score of 0.46 beat KORU Medical Systems' score of 0.46 indicating that Allurion Technologies is being referred to more favorably in the media.
Allurion Technologies has a beta of -0.13, suggesting that its stock price is 113% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500.
21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 20.0% of Allurion Technologies shares are held by company insiders. Comparatively, 25.6% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
KORU Medical Systems beats Allurion Technologies on 8 of the 15 factors compared between the two stocks.
Get Allurion Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Allurion Technologies Competitors List
Related Companies and Tools
